ALLIANCE PHARMA PLC

Remuneration Information • Apr 11, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6773E

Alliance Pharma PLC

11 April 2014

For immediate release	11 April 2014

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 11 April 2014 it awarded the following options over ordinary shares of the Company to certain Directors.

Name	Position	Number of Share Options Awarded	Exercise price per Share	Date of vesting	Percentage of issued ordinary share capital
Anthony Booley	Executive Director	144,200	33.75p	11 April 2017	0.055
Peter Butterfield	Executive Director	144,200	33.75p	11 April 2017	0.055
Richard Wright	Finance Director	144,200	33.75p	11 April 2017	0.055

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Oliver Cardigan / Freddie Barnfield
Corporate Broking: David Poutney

Notes to editors:

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKDDBNBKDPQD